BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34836115)

  • 1. Effect of Geumgwe-Sinkihwan on Renal Dysfunction in Ischemia/Reperfusion-Induced Acute Renal Failure Mice.
    Han BH; Lee HK; Jang SH; Tai AL; Jang YJ; Yoon JJ; Kim HY; Lee HS; Lee YJ; Kang DG
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D1 receptor agonist A68930 attenuates acute kidney injury by inhibiting NLRP3 inflammasome activation.
    Cao JY; Zhou LT; Li ZL; Yang Y; Liu BC; Liu H
    J Pharmacol Sci; 2020 Jul; 143(3):226-233. PubMed ID: 32446726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demotion of canonical/non-canonical inflammasome and pyroptosis alleviates ischemia/reperfusion-induced acute kidney injury: Novel role of the D2/D3 receptor agonist ropinirole.
    Henedak NT; El-Abhar HS; Abdallah DM; Ahmed KA; Soubh AA
    Eur J Pharmacol; 2024 Apr; 969():176460. PubMed ID: 38402931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
    Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J
    J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetramethylpyrazine alleviates acute kidney injury by inhibiting NLRP3/HIF‑1α and apoptosis.
    Sun W; Li A; Wang Z; Sun X; Dong M; Qi F; Wang L; Zhang Y; Du P
    Mol Med Rep; 2020 Oct; 22(4):2655-2664. PubMed ID: 32945382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation.
    Tang TT; Lv LL; Pan MM; Wen Y; Wang B; Li ZL; Wu M; Wang FM; Crowley SD; Liu BC
    Cell Death Dis; 2018 Mar; 9(3):351. PubMed ID: 29500339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role of silymarin in a mouse model of renal Ischemia-Reperfusion injury.
    Tan J; Hu J; He Y; Cui F
    Diagn Pathol; 2015 Oct; 10():198. PubMed ID: 26521234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine ameliorates renal ischemia reperfusion-mediated activation of the NLRP3 inflammasome in alveolar macrophages.
    Chen Y; Huang Y; Xiong B; Luo H; Song X
    Gene; 2020 Oct; 758():144973. PubMed ID: 32707303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen sulfide attenuates renal I/R‑induced activation of the inflammatory response and apoptosis via regulating Nrf2‑mediated NLRP3 signaling pathway inhibition.
    Su Y; Wang Y; Liu M; Chen H
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34013370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injury.
    Kim HJ; Lee DW; Ravichandran K; O Keys D; Akcay A; Nguyen Q; He Z; Jani A; Ljubanovic D; Edelstein CL
    J Pharmacol Exp Ther; 2013 Sep; 346(3):465-72. PubMed ID: 23833276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin Ameliorates Ischemia/Reperfusion-Induced Acute Kidney Injury via Inflammasome Suppression in Mice.
    Kwak J; Kim JH; Jang HN; Jung MH; Cho HS; Chang SH; Kim HJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32414157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sinkihwan-gamibang ameliorates puromycin aminonucleoside-induced nephrotic syndrome.
    Lee HK; Jang YJ; Na SW; Kim HY; Han BH; Lee YJ; Lee HS; Yoon JJ; Kang DG
    Chin J Nat Med; 2022 Mar; 20(3):177-184. PubMed ID: 35369961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treprostinil, a prostacyclin analog, ameliorates renal ischemia-reperfusion injury: preclinical studies in a rat model of acute kidney injury.
    Ding M; Tolbert E; Birkenbach M; Akhlaghi F; Gohh R; Ghonem NS
    Nephrol Dial Transplant; 2021 Jan; 36(2):257-266. PubMed ID: 33156922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone ameliorates ischemia/reperfusion-induced acute kidney injury via oxidative stress attenuation and NLRP3 inflammasome.
    Ye Z; Zhang J; Xu Z; Li Z; Huang G; Tong B; Xia P; Shen Y; Hu H; Yu P; Xi X
    Hum Cell; 2024 Jul; 37(4):959-971. PubMed ID: 38607518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway.
    Ma C; Wang X; Xu T; Yu X; Zhang S; Liu S; Gao Y; Fan S; Li C; Zhai C; Cheng F; Wang Q
    BMC Complement Altern Med; 2019 Nov; 19(1):320. PubMed ID: 31747940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
    Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
    J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mROS-TXNIP axis activates NLRP3 inflammasome to mediate renal injury during ischemic AKI.
    Wen Y; Liu YR; Tang TT; Pan MM; Xu SC; Ma KL; Lv LL; Liu H; Liu BC
    Int J Biochem Cell Biol; 2018 May; 98():43-53. PubMed ID: 29477360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pirfenidone attenuates gentamicin-induced acute kidney injury by inhibiting inflammasome-dependent NLRP3 pathway in rats.
    Sharawy MH; Serrya MS
    Life Sci; 2020 Nov; 260():118454. PubMed ID: 32950575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel eCIRP/TREM-1 pathway inhibitor attenuates acute kidney injury.
    Siskind S; Royster W; Brenner M; Wang P
    Surgery; 2022 Aug; 172(2):639-647. PubMed ID: 35292178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-O-methyldihydroquercetin and cilicicone B isolated from Spina Gleditsiae ameliorate lipopolysaccharide-induced acute kidney injury in mice by inhibiting inflammation and oxidative stress via the TLR4/MyD88/TRIF/NLRP3 signaling pathway.
    Zeng M; Qi M; Wang Y; Xu R; Wu Y; Li M; Zheng X; Feng W
    Int Immunopharmacol; 2020 Mar; 80():106194. PubMed ID: 31986326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.